Fredun Pharmaceuticals
add_icon

Fredun Pharmaceuticals

1,917.45
+32.50
(1.72%)
Market Cap
₹- Cr
PE Ratio
-
Volume
2,516.00
Day High - Low
₹1,924.80 - ₹1,862.00
52W High-Low
₹1,999.00 - ₹635.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
333.04
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
neutral
Fredun Pharmaceuticals provided updated disclosure of Ultimate Beneficial Owners and pre-preferential shareholding details for proposed allottees following its Extra-Ordinary General Meeting held on October 22, 2025. The company outlined its strategic expansion into integrated health, wellness and pharmaceutical sectors with fund allocation across brand marketing (35%), working capital (35%), and other operational requirements including expansion into nine international markets.
positive
Fredun Pharmaceuticals Appoints Independent Director and Company Secretary6 days ago
Fredun Pharmaceuticals appointed Ms. Pooja Narendra Sanghavi as Additional Independent Director for five years and Ms. Vaishnavi Sahu as Company Secretary and Compliance Officer, both effective November 28, 2025. The appointments strengthen the company's board composition and compliance framework, with the independent director appointment subject to shareholder approval.
neutral
Fredun Pharmaceuticals Limited announced the comprehensive list of Ultimate Beneficial Owners (UBOs) for proposed allottees in connection with preferential allotment of equity shares and warrants approved at the Extra-Ordinary General Meeting held on October 22, 2025. The disclosure includes 17 proposed allottees with their respective UBO details, superseding earlier communications and ensuring complete transparency and regulatory compliance for the preferential allotment process.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
0
0
286
165
119
144
Expenses
0
0
251
150
103
123
EBITDA
0
0
35
15
17
21
Operating Profit %
0 %
0 %
12 %
9 %
14 %
14 %
Depreciation
0
0
3
2
1
2
Interest
0
0
14
8
7
8
Profit Before Tax
0
0
20
7
9
13
Tax
0
0
7
1
2
3
Net Profit
0
0
14
6
7
9
EPS in ₹
0.00
0.00
29.09
12.71
14.33
19.98

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
23
43
56
79
105
141
162
187
257
308
487
Fixed Assets
8
15
16
16
31
31
30
32
39
47
53
Current Assets
13
28
35
52
73
109
130
153
216
257
428
Capital Work in Progress
1
0
4
11
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
1
240
Other Assets
14
29
36
52
74
110
131
155
218
260
0
Total Liabilities
23
43
56
79
105
141
162
187
257
308
487
Current Liabilities
16
32
41
43
53
86
87
74
140
167
327
Non Current Liabilities
4
7
8
14
13
14
32
45
21
19
18
Total Equity
3
4
7
22
39
41
43
68
96
122
141
Reserve & Surplus
1
1
2
19
35
37
39
63
84
115
137
Share Capital
3
3
5
3
4
4
4
4
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-1
1
0
2
-2
1
1
-2
Investing Activities
-3
-6
-7
-8
-5
-2
-1
-4
-9
-8
Operating Activities
2
3
4
17
1
-11
0
-2
-14
-0
Financing Activities
1
4
3
-8
4
14
-1
8
25
6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
May 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
52.04 %
52.04 %
52.04 %
51.27 %
51.27 %
51.27 %
51.04 %
51.04 %
50.34 %
50.15 %
49.62 %
49.62 %
49.33 %
49.31 %
49.16 %
49.17 %
48.92 %
49.17 %
48.93 %
48.93 %
48.93 %
48.93 %
48.93 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
DIIs
1.88 %
1.88 %
1.88 %
1.69 %
1.69 %
1.69 %
1.68 %
1.68 %
1.66 %
1.65 %
1.64 %
1.64 %
1.61 %
1.60 %
1.60 %
1.60 %
1.59 %
1.60 %
1.59 %
1.59 %
1.59 %
1.59 %
1.60 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.01 %
40.99 %
40.77 %
41.56 %
41.90 %
41.81 %
42.02 %
42.08 %
42.48 %
43.07 %
43.64 %
43.60 %
43.48 %
43.49 %
43.67 %
44.02 %
43.94 %
43.89 %
44.21 %
44.55 %
44.50 %
44.52 %
43.74 %
Others
5.07 %
5.09 %
5.32 %
5.47 %
5.13 %
5.23 %
5.25 %
5.19 %
5.52 %
5.13 %
5.10 %
5.14 %
5.58 %
5.60 %
5.58 %
5.22 %
5.55 %
5.35 %
5.27 %
4.93 %
4.98 %
4.96 %
5.72 %
No of Share Holders
0
1,993
2,301
3,681
3,674
3,573
3,620
3,678
3,901
4,521
4,609
4,625
4,627
4,635
6,315
7,507
6,840
7,511
8,018
8,121
7,976
7,906
8,120

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.6 1 0.65 0.66 0.7 0.7 0.7 0.7 0.00
Dividend Yield (%) 0.00 0.42 0.24 0.56 0.14 0.08 0.09 0.1 0.1 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2021 DIVIDEND Dividend
0.70 /share
16 Sept 2021 415.70 454.45
22 Sept 2023 DIVIDEND Dividend
0.70 /share
22 Sept 2023 886.50 875.65
18 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Jan 2024 872.05 837.70
23 Sept 2024 DIVIDEND Dividend
0.70 /share
23 Sept 2024 981.65 767.60
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 788.20 755.65
26 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Oct 2024 774.70 726.85
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 700.70 721.85
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 724.55 771.00
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 860.20 958.60
23 Sept 2025 DIVIDEND Dividend
0.70 /share
23 Sept 2025 771.65 1,216.75
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 1,211.90 1,309.50
22 Oct 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
22 Oct 2025 1,306.50 1,660.80
08 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2025 1,723.30 1,551.30

Announcements

Corrigendum Through General Announcement Regarding Disclosure Of Ultimate Beneficial Owners (Ubos) Pre -Preferential Shareholding Of Proposed Allottees And Bifurcation And Brief Description Of The Object In Connection With The Extra-Ordinary General Meeti5 days ago
Appointment of Company Secretary and Compliance Officer6 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate6 days ago
Announcement under Regulation 30 (LODR)-Change in Management6 days ago
General Announcement Pertaining To Disclosure Of Ultimate Beneficial Owners (Ubos) Of Proposed Allottees In Connection With The Extra-Ordinary General Meeting (EGM) Held On October 22 2025.Nov 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Audio Recording Of The Q2 FY26 Earnings Conference CallNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 10, 2025
Revised Outcome Of Board MeetingNov 09, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 08, 2025
Outcome Of Board MeetingNov 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting.Nov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Saturday 08Th November 2025Oct 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMOct 22, 2025
Corrigendum I To The Notice Of Extraordinary General Meeting.Oct 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 09, 2025
Announcement under Regulation 30 (LODR)-CessationOct 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Intimation Of Record Date For The Purpose Of EOGM Of The Company.Sep 30, 2025
Notice Of Book Closure For The Purpose Of Extra Ordinary General Meeting To Be Held On 22Nd October 2025.Sep 30, 2025
Notice Convening Extra-Ordinary General Meeting (EOGM) Of Fredun Pharmaceuticals LimitedSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2025
Closure of Trading WindowSep 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th September 2025 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Sep 25, 2025
Closure of Trading WindowSep 22, 2025
Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (The SEBI LODR Regulations)Sep 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").Sep 08, 2025
Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2024-25Sep 08, 2025
Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM)Sep 08, 2025
Submission Of The 38Th Annual Report Of Fredun Pharmaceuticals Limited For The Financial Year 2024-25.Sep 08, 2025
Reg. 34 (1) Annual Report.Sep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesSep 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 06, 2025
Audio Recording Of The Q1 FY26 Earnings Conference CallAug 01, 2025
Audio Recording Of The Q1 FY25 Earnings Conference CallAug 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Appointment Of Non-Executive Independent Directors.Jul 30, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 30, 2025

Technical Indicators